Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

Robert Thimme1, Jens Bukh1, Hans Christian Spangenberg1, Stefan Wieland1, Janell Pemberton1, Carola Steiger1, Sugantha Govindarajan1, Robert H. Purcell1, Francis V. Chisari1
1Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA 92037; University Hospital Freiburg, Department of Medicine II, Hugstetterstrasse 55, 79106 Freiburg, Germany Europe; Hepatitis Viruses Section, Laboratory of Infectious Diseases, National Institutes of Health, Bethesda, MD 20892; and Liver Research Laboratory, Rancho Los Amigos Medical Center, Downey, CA 90242

Tóm tắt

To define the early events that determine the outcome of acute hepatitis C virus (HCV) infection, we compared the course of viremia with the peripheral and intrahepatic T cell response and intrahepatic cytokine profile in six acutely infected chimpanzees. Three different outcomes were observed after peak viral titers were reached: sustained viral clearance, transient viral clearance followed by chronic infection, and chronic infection that persisted at initial peak titers. The results indicate that HCV spread outpaces the T cell response and that HCV rapidly induces but is not controlled by IFN-α/β; that viral clearance follows the entry and accumulation of HCV-specific IFN-γ-producing T cells in the liver; and that it may not require the destruction of infected cells.

Từ khóa


Tài liệu tham khảo

10.1046/j.1365-2249.2002.01840.x

10.1016/S0140-6736(95)91691-1

10.1086/315450

10.1016/S0016-5085(99)70353-7

10.1002/1521-4141(200009)30:9<2479::AID-IMMU2479>3.0.CO;2-B

10.1084/jem.191.9.1499

10.1172/JCI118842

10.1084/jem.194.10.1395

Wong D. K., Dudley, D. D., Afdhal, N. H., Dienstag, J., Rice, C. M., Wang, L., Houghton, M., Walker, B. D. & Koziel, M. J. (1998) J. Immunol.160,1479-1488.9570570

10.1128/JVI.75.3.1229-1235.2001

Koziel M. J., Dudley, D., Wong, J. T., Dienstag, J., Houghton, M., Ralston, R. & Walker, B. D. (1992) J. Immunol.149,3339-3344.1385523

10.1073/pnas.96.10.5692

10.1002/1521-4141(200108)31:8<2388::AID-IMMU2388>3.0.CO;2-L

10.1016/S1074-7613(00)80044-8

Erickson A. L., Houghton, M., Choo, Q. L., Weiner, A. J., Ralston, R., Muchmore, E. & Walker, C. M. (1993) J. Immunol.151,4189-4199.7691940

10.1016/S1074-7613(01)00245-X

10.1084/jem.183.4.1761

10.1073/pnas.92.7.2755

10.1086/314653

10.1053/jhep.2000.9877

10.1073/pnas.96.5.2291

10.1073/pnas.230453597

10.1016/S1074-7613(00)80295-2

10.1016/0016-5085(93)90430-K

10.1002/hep.1840190205

10.1128/jvi.70.10.7092-7102.1996

10.1126/science.2523562

10.1128/jvi.69.4.2462-2470.1995

10.1172/JCI117694

Chang K. M., Gruener, N. H., Southwood, S., Sidney, J., Pape, G. R., Chisari, F. V. & Sette, A. (1999) J. Immunol.162,1156-1164.9916747

10.1172/JCI118287

10.1128/jvi.67.12.7522-7532.1993

10.1086/515255

10.1128/jvi.66.5.2670-2678.1992

10.1126/science.284.5415.825

10.1053/jhep.2002.31770

10.1128/JVI.75.12.5550-5558.2001

10.4049/jimmunol.169.6.3447

10.1016/S1074-7613(01)00154-6

10.1084/jem.20011124

10.1084/jem.20011145

10.1038/82161

10.1146/annurev.immunol.19.1.47

10.1006/viro.2001.0885

10.1073/pnas.202608199